Skip to main content

Featured

'Silver economy' panel set up

The Commerce & Economic Development Bureau today established the Advisory Panel on Silver Economy and convened its first meeting with the aim of initiating research on the development of Hong Kong’s growing elderly population as a consumer segment.    Chairing the panel, Secretary for Commerce & Economic Development Algernon Yau said the elderly demographic was emerging as an important part of the city’s economy.    He highlighted that many products and services designed to enhance the quality of life enjoyed by elderly residents are spurring growth and business opportunities.    Mr Yau added that promoting such products and services can help to foster the development of the so-called silver economy and unleash business potential in the elderly market, whilst also catering to the aspirations and needs of elderly people. He said this would be the advisory panel’s focus.     At today’s meeting, the panel endorsed its terms of reference, reviewed statistics relating to

Vaccine packaging issue probed

(To watch the full media session with sign language interpretation, click here.)   An investigation by BioNTech has revealed that packaging defects in its COVID-19 vaccine vials were caused by the crimping process and ultra-low storage temperature but did not affect the jabs' safety.   Director of Health Dr Constance Chan told a media session this afternoon that the Department of Health received a written notification from BioNTech today on its investigation into the packaging issue.   Dr Chan said: “Upon further investigation, samples (of the BioNTech vaccine vials with packaging defects) detected in Hong Kong were sent back to Germany for an investigation. They have done numerous tests and experiments on the vials concerned. They have also done tests in another fill and finish plant operated by Baxter.   “In the process, they found out that in the vials packed at the site which provided batches (numbered) 210102 and 210104, there were issues related to the so-called crimping process. Crimping is the process by which pressure is applied to the aluminium ring which affixes to the rubber stopper at the top of the vial.   “We received a report that the (defect in question) is related to the process of crimping and at the same time the condition of the ultra-low temperature of minus 70 degrees Celsius. So that is why BioNTech has now decided to send the new vials from Baxter which have undergone repeated experiments and investigations, and that would exclude further occurrence of such an event.”
http://dlvr.it/RwqJtL

Popular Posts